McDermott Will and Emery represented Portage Biotech Inc. in the transaction. Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase […]
Portage Biotech’s Acquisition of Tarus Therapeutics
Pasithea Therapeutics’ Acquisition of Alpha-5 Integrin
McDermott Will & Emery represented Pasithea Therapeutics Corp. in the transaction. Pasithea Therapeutics Corp. (Pasithea), a US biotechnology company focused on the research and discovery of […]
Zura Bio’s Business Combination with JATT Acquisition Corp.
McDermott Will & Emery and Ogier represented Zura Bio. Loeb & Loeb and Simmons & Simmons represented JATT and Maples and Calder (Cayman) acted as Cayman […]
PowerUp Acquisition Corp’s $250 Million Initial Public Offering
McDermott Will & Emery represented PowerUp Acquisition Corp in the offering. PowerUp Acquisition Corp., a video game-focused special purpose acquisition company (SPAC), completed its $250 million […]
Signal Hill Acquisition Corp.’s $100 Million Initial Public Offering
McDermott Will & Emery represented B. Riley Securities Inc. in the offering. Signal Hill Acquisition Corp., a special purpose acquisition company (SPAC), executed its $100 million […]
CHW Acquisition Corporation’s $350 Million De-SPAC With Wag Labs
McDermott Will & Emery represented CHW Acquisition Corporation, while Cleary Gottlieb Steen & Hamilton represented Wag! in the transaction. CHW Acquisition Corporation (CHW), a publicly traded […]
Papaya Growth Opportunity Corp. I’s $250 Million Initial Public Offering
McDermott Will & Emery represented Papaya Growth Opportunity Corp. I in the transaction. Papaya Growth Opportunity Corp. I (NASDAQ: PPYAU), a newly incorporated blank check company, […]
TeleSign’s Business Combination With North Atlantic Acquisition Corporation
Reed Smith and McDermott Will & Emery LLP acted as legal counsel to NAAC. Sidley Austin acted as legal counsel to Morgan Stanley and J.P. Morgan […]